Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2010
08/11/2010CN101801370A Composition comprising sesamin component and arachidonic acid component
08/11/2010CN101801363A Cholesterol-control agent
08/11/2010CN101798356A Method for separating and extracting natural tea polysaccharide
08/11/2010CN101798347A Monoclonal antibody for resisting high mobility group protein B1
08/11/2010CN101798284A Azepine brazilin compound and synthesis method thereof
08/11/2010CN101797385A Oral calcium pharmaceutical composition
08/11/2010CN101797376A Preparation method of modified collagen film
08/11/2010CN101797371A Drug combination for weight-reducing massage
08/11/2010CN101797346A Qiqing traditional Chinese medicine tea for lowering blood pressure, lowering blood lipid and lowering blood sugar level and preparation method thereof
08/11/2010CN101797341A Chinese herbal medicine pill capable of clearing blood fat and lowering blood pressure
08/11/2010CN101797330A Lipid regulating and meridians activating capsule
08/11/2010CN101797312A Method for preparing Alisma extract capable of inhibiting alpha-glucuroide activity
08/11/2010CN101797310A Fat reduction traditional Chinese medicine composite capable of removing dampness and absorbing clot as well as activating blood circulation and dissipating blood stasis
08/11/2010CN101797282A Novel compound propolis preparation and preparation method thereof
08/11/2010CN101797281A Medicinal granules for toxin elimination and blood fat reduction
08/11/2010CN101797276A Compound vitamin nanoemulsion
08/11/2010CN101797272A Fungus compound agent with antifatigue function
08/11/2010CN101797270A Silkworm pupal oil fat emulsion intravenous fluid and preparation method
08/11/2010CN101797259A Compound vitamin nanoemulsion
08/11/2010CN101797245A Nanoparticulate fibrate formulations
08/11/2010CN101797234A Pramlintide acetate slow release microballoon preparation and preparation method thereof
08/11/2010CN101797233A Nanoparticulate fibrate formulations
08/11/2010CN101797227A High oxidation resistance long chain fat emulsion injection and preparation method thereof
08/11/2010CN101797226A High oxidation resistance medium/long chain fat emulsion injection and preparation method thereof
08/11/2010CN101797225A High oxidation resistance long chain fat emulsion injection and preparation method thereof
08/11/2010CN101317869B Method for extracting flavone from capillary wormwood
08/11/2010CN101301476B Hydrophobic cyclodextrin clathrate and preparation and use thereof
08/11/2010CN101219208B Medicine use of interleukin-22
08/11/2010CN101181520B Chinese traditional medicine tonic wine for tonifying kidney and nourishing blood
08/11/2010CN101161268B Pharmaceutical composition of red sage root and cattail pollen
08/11/2010CN101073574B Medicine for treating diabetes mellitus
08/11/2010CN101011145B Edible Collybia albuminosa(Berk.) Petch stuffing
08/11/2010CN100999546B Polypeptide compound with aza-containing heterocyclic modification and its application
08/10/2010US7772429 chemical intermediate 11-((4R,6R)-4,5,6-trihydroxy-3-(R)-hydroxy-2-(S)-hydroxyhexylcarbamoyl)undecanoic acid; for making antilipemic agents; anticholesterol agents
08/10/2010US7772407 (1S)-1,5-anhydro-1-[3-(1-benzothien-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity
08/10/2010US7772402 Optically detectable organophosphonates
08/10/2010US7772272 Method for enhancing glucose uptake into warm-blooded animal adipocytes
08/10/2010US7772260 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases
08/10/2010US7772249 Imidazo[1,2-b]pyridazine compound
08/10/2010US7772232 Quinazolinyl compounds as inhibitors of potassium channel function
08/10/2010US7772226 such as 3-(2-Butynyl)-2-(piperazin-1-yl)-3,5-dihydroimidazo[4,5-d]pyridazin-4-one trifluoroacetate, used as dipeptidyl peptidase-IV (DPPIV) inhibitors for the treatment of obesity and diabetes
08/10/2010US7771771 fatty acid esters of phytosterols and phytostanols; preparing an edible oil or fat blend with elevated sterol and/or stanol content comprising liquid vegetable oil and a sterol and/or stanol fatty acid ester composition
08/10/2010US7771748 Reducing smoking; side effect reduction
08/10/2010CA2488592C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/10/2010CA2477967C Purine derivatives as kinase inhibitors
08/10/2010CA2471745C 25-hydroxy vitamin d3 compositions
08/10/2010CA2440714C Pyrazolopyrimidines as therapeutic agents
08/10/2010CA2366800C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/10/2010CA2362864C New gymnemic acid derivatives, their preparation, pharmaceutical composition containing them and their medical use
08/10/2010CA2249542C Pyrazole derivatives, their preparation and their use in pharmaceuticals
08/10/2010CA2215827C O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof
08/05/2010WO2010088574A1 Azabenzimidazoles and related analogs as sirtuin modulators
08/05/2010WO2010088518A2 Heterocyclic modulators of gpr119 for treatment of disease
08/05/2010WO2010088415A2 Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity
08/05/2010WO2010088392A1 Carboxamide compounds and methods for using the same
08/05/2010WO2010088375A2 Method of synergistically enhancing the therapeutic efficacy and safety of medications through a combination therapy
08/05/2010WO2010088071A1 Use of whole grain materials with high resistant starch for satiety, reduction of food intake and weight management
08/05/2010WO2010087577A2 Use of thymus capitatus extract, satureja hortensis extract, or carvacrol for treating metabolic diseases
08/05/2010WO2010087517A1 Prophylactic or therapeutic agent for diseases associated with abnormal bone metabolism
08/05/2010WO2010087454A1 Quinoline derivative
08/05/2010WO2010087399A1 Urotensin-ii receptor antagonists
08/05/2010WO2010087373A1 Method for producing extract of astaxanthin-containing yeast belonging to genus phaffia
08/05/2010WO2010087244A1 Cyclic amino alcohol compound
08/05/2010WO2010087243A1 Adiponectin-containing eating behavior control agent for oral administration
08/05/2010WO2010087150A1 Gastric acid secretion inhibitor, and potassium channel inhibitor
08/05/2010WO2010086820A1 4-amino-5-oxo-7, 8-dihydropyrimido [5,4-f] [1,4] oxazepin-6 (5h) -yl) phenyl derivatives, pharmaceutical compositions and uses thereof
08/05/2010WO2010086646A1 Scriptaid isosteres and their use in therapy
08/05/2010WO2010086484A1 Use of derivates of 6-substituted 3-phenylcoumarins and preparation of new derivates
08/05/2010WO2010086454A1 N-(phenyl or pyridyl)prenylamine derivatives for the treatment of obesity, diabetes, cardiovascular diseases and other adiponectin-related diseases
08/05/2010WO2010086438A1 Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof
08/05/2010WO2010086411A1 Dpp-iv inhibitors for treatment of diabetes in paediatric patients
08/05/2010WO2010086322A1 Composition comprising chicoric acid and/or derivatives thereof
08/05/2010WO2010086101A1 Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof
08/05/2010WO2010068913A3 Compositions of proton pump inhibitors, kits and methods of their use to treat diabetes
08/05/2010WO2010066931A4 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug
08/05/2010WO2010066901A3 Tetrahydrotriazine compounds for treating diseases associated with ampk activity
08/05/2010WO2010046474A3 Chemoattractants inhibitors and the use thereof
08/05/2010WO2010045303A3 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof
08/05/2010WO2010017570A3 Pharmaceutical form comprising tetrahydrobiopterin
08/05/2010WO2009100872A8 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/05/2010WO2003060149A9 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/05/2010US20100199366 Gene therapy using transposon-based vectors
08/05/2010US20100197917 Coumarin derivatives useful as tnf alpha inhibitors
08/05/2010US20100197911 Nitrogen-Containing Aromatic Derivatives
08/05/2010US20100197907 Phosphorus-containing compounds & uses thereof
08/05/2010US20100197803 Method for obtaining a sequoyitol-containing extract from a plant of the genus of trifolium, leguminosae or ginkoaceae and uses thereof
08/05/2010US20100197801 Volatile Distillate By-Product of Mint Oil That Promotes Absorption and/or Bioavailability of Compounds of Bio-Medical and Nutritional Interest
08/05/2010US20100197789 Anti-obesity agent and use thereof
08/05/2010US20100197787 Composition for Prevention of Hypoglycemic Condition
08/05/2010US20100197779 Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury
08/05/2010US20100197778 Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases
08/05/2010US20100197764 Antisense modulation of acyl coa cholesterol acyltransferase-2 expression
08/05/2010US20100197744 Organic Compounds
08/05/2010US20100197736 Cetp activity inhibitors
08/05/2010US20100197735 Novel phenylurea inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof
08/05/2010US20100197732 Repaglinide Substantially Free of Dimer Impurity
08/05/2010US20100197726 Inhibitor of the differentiation of t cells into th1 cells
08/05/2010US20100197714 Spiro-pyrano-pyrazole derivatives
08/05/2010US20100197710 Methods Of Activating IRS-1 And AKT
08/05/2010US20100197708 Indole compounds